NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company ...
Roman DBDR Acquisition Corp. II Announces Receipt of Nasdaq Deficiency Letter Provided by PR Newswire Sep 18, 2025, 2:00:00 PM Roman DBDR Acquisition Corp. II Announces Receipt of Nasdaq Deficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback